CCL5 is associated with obesity-induced cardiovascular disease and insulin resistance, and has effects on mitochondrial oxidative phosphorylation and fatty acid metabolic pathways. When the binding signal of CCL5 and its receptor is enhanced, it inhibits AMPK activity, which leads to a decrease in lipolysis and oxidative metabolism. The gene discussed is CCL5; the disease is Insulin resistance.